title: p27 deficiency desensitizes Rb-/- cells to signals that trigger apoptosis during pituitary tumor development.
abstract: Low p27 expression in many human cancers is a prognostic indicator for poor outcome. While analysing the mechanism by which p27 deficiency contributed to tumor development in the Rb+/- mouse model, we identified a role for p27 as a proapoptotic tumor suppressor. We examined the cell cycle and apoptotic response of these pituitary tumor cells to the dopamine analog bromocriptine as well as the expression of Arf and other cell cycle and apoptotic regulators in these tumors. We also examined the expression of Arf and its function in mouse embryo fibroblasts either singly or doubly deficient for Rb and p27. From these studies, we concluded that the absence of p27 disabled the trigger for an Arf-dependent apoptotic response in Rb-/- tumor cells. This suggests a novel mechanism by which the loss of p27 may impact on tumor development.
authors.affiliation: Department of Molecular Biology, Menmorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.
authors.forename: Carmen
authors.initials: C
authors.lastname: Carneiro
authors.forename: Maria Socorro
authors.initials: MS
authors.lastname: Jiao
authors.forename: Ming
authors.initials: M
authors.lastname: Hu
authors.forename: David
authors.initials: D
authors.lastname: Shaffer
authors.forename: Michele
authors.initials: M
authors.lastname: Park
authors.forename: Pier Paolo
authors.initials: PP
authors.lastname: Pandolfi
authors.forename: Carlos
authors.initials: C
authors.lastname: Cordon-Cardo
authors.forename: Andrew
authors.initials: A
authors.lastname: Koff
mesh_terms: D000818:Animals; D017209:Apoptosis / Q000235:genetics*; D001971:Bromocriptine / Q000494:pharmacology; D002453:Cell Cycle / Q000235:genetics; D018797:Cell Cycle Proteins / Q000235:genetics / Q000378:metabolism*; D002455:Cell Division / Q000235:genetics; D019941:Cyclin-Dependent Kinase Inhibitor p16; D050760:Cyclin-Dependent Kinase Inhibitor p27; D004298:Dopamine / Q000494:pharmacology; D018491:Dopamine Agonists / Q000494:pharmacology; D005347:Fibroblasts / Q000473:pathology; D051379:Mice; D008817:Mice, Mutant Strains; D010902:Pituitary Gland / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D010911:Pituitary Neoplasms / Q000235:genetics* / Q000473:pathology; D016160:Retinoblastoma Protein / Q000235:genetics* / Q000378:metabolism; D015398:Signal Transduction; D025803:Tumor Suppressor Protein p14ARF / Q000235:genetics / Q000378:metabolism; D025521:Tumor Suppressor Proteins / Q000172:deficiency / Q000235:genetics / Q000378:metabolism*
chemical_list: C493961:Cdkn1b protein, mouse; C417743:Cdkn2a protein, mouse; D018797:Cell Cycle Proteins; D019941:Cyclin-Dependent Kinase Inhibitor p16; D018491:Dopamine Agonists; D016160:Retinoblastoma Protein; D025803:Tumor Suppressor Protein p14ARF; D025521:Tumor Suppressor Proteins; D050760:Cyclin-Dependent Kinase Inhibitor p27; D001971:Bromocriptine; D004298:Dopamine